CV SCIENCES, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.038 USD | 0.00% |
|
0.00% | +7.34% |
| Mar. 28 | Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
| Mar. 28 | CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Greetings, and welcome to the CV Sciences' Thi...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). It also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands, such as +PlusCBD and Cultured Foods in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its +PlusCBD branded products are sold at select retail locations throughout the United States. The Company's Cultured Foods brand provides a variety of 100% plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience.
Sector
Pharmaceuticals
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.34% | 6.19M | |
| +27.74% | 659B | |
| +27.68% | 557B | |
| -4.10% | 359B | |
| +16.44% | 322B | |
| +9.11% | 297B | |
| +6.30% | 215B | |
| +4.80% | 210B | |
| -6.05% | 200B | |
| -8.74% | 149B |
- Stock Market
- Equities
- CVSI Stock
- News CV Sciences, Inc.
- Transcript : CV Sciences, Inc., Q3 2022 Earnings Call, Nov 14, 2022
